Clinical Trials List
Protocol NumberAP-0103
Completed
2023-05-10 - 2025-04-30
Phase II
Terminated3
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
12 participants